These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9768734

  • 1. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.
    Ricciardi MJ, Knight BP, Martinez FJ, Rubenfire M.
    J Am Coll Cardiol; 1998 Oct; 32(4):1068-73. PubMed ID: 9768734
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Echocardiographic predictors of an adverse response to a nifedipine trial in primary pulmonary hypertension: diminished left ventricular size and leftward ventricular septal bowing.
    Ricciardi MJ, Bossone E, Bach DS, Armstrong WF, Rubenfire M.
    Chest; 1999 Nov; 116(5):1218-23. PubMed ID: 10559078
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange.
    Jolliet P, Bulpa P, Thorens JB, Ritz M, Chevrolet JC.
    Thorax; 1997 Apr; 52(4):369-72. PubMed ID: 9196521
    [Abstract] [Full Text] [Related]

  • 5. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Apr; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
    Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J.
    Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
    Cockrill BA, Kacmarek RM, Fifer MA, Bigatello LM, Ginns LC, Zapol WM, Semigran MJ.
    Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S, Schrader BJ, Kaufmann E, Vestal RE, Rich S.
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension.
    Williamson DJ, Hayward C, Rogers P, Wallman LL, Sturgess AD, Penny R, Macdonald PS.
    Circulation; 1996 Aug 01; 94(3):477-82. PubMed ID: 8759092
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.
    Eur J Cardiothorac Surg; 2002 Nov 01; 22(5):746-52. PubMed ID: 12414041
    [Abstract] [Full Text] [Related]

  • 16. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
    Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS.
    Chest; 2001 Sep 01; 120(3):866-72. PubMed ID: 11555522
    [Abstract] [Full Text] [Related]

  • 17. Inhaled nitric oxide for pulmonary hypertension after heart transplantation.
    Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H.
    Transplantation; 2001 Aug 27; 72(4):638-41. PubMed ID: 11544423
    [Abstract] [Full Text] [Related]

  • 18. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE.
    Chest; 1998 Sep 27; 114(3):780-6. PubMed ID: 9743166
    [Abstract] [Full Text] [Related]

  • 19. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.
    Atz AM, Adatia I, Lock JE, Wessel DL.
    J Am Coll Cardiol; 1999 Mar 27; 33(3):813-9. PubMed ID: 10080486
    [Abstract] [Full Text] [Related]

  • 20. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW, Deb B, Kavanagh BP, Pearl RG.
    Pharmacology; 1999 May 27; 58(5):246-51. PubMed ID: 10087465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.